Basics Passage Bio, Inc. IPO Date: February 28, 2020 Sector: Healthcare Industry: Biotech Market Cap: $22.82M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 4.24% Avg Daily Range (30 D): $0.32 | 4.79% Avg Daily Range (90 D): $0.16 | 5.92% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .04M Avg Daily Volume (90 D): .19M Trade Size Avg Trade Size (Sh.): 137 Avg Trade Size (Sh.) (30 D): 45 Avg Trade Size (Sh.) (90 D): 181 Institutional Trades Total Inst.Trades: 245 Avg Inst. Trade: $1.96M Avg Inst. Trade (30 D): $1.33M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.49M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 162.16K     News Mar 4, 2025 @ 3:55 PM 2025 Market Prospects of Adeno-Associated Virus Ve... Source: Researchandmarkets.Com Feb 26, 2025 @ 12:00 PM Passage Bio to Participate in Upcoming Investor Co... Source: N/A Nov 6, 2024 @ 12:00 PM Passage Bio to Present at Guggenheim Securities He... Source: N/A Aug 30, 2024 @ 11:00 AM Passage Bio to Present at H.C. Wainwright 26th Ann... Source: N/A Jul 16, 2024 @ 11:11 AM Passage Bio Announces Positive Feedback from FDA o... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.72 $-2.96 $-.25 Diluted EPS $-3.72 $-2.96 $-.25 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -56.86M $ -9.39M $ -15.41M Operating Income / Loss $ -61.77M $ -10.33M $ -16.46M Cost of Revenue $ $ $ Net Cash Flow $ 32.86M $ 20.05M $ M PE Ratio     Splits Jun 01, 2004:   20:1